Продажа автомобилей Ford Форд

Авторынок FordРегистрацияВход


Приветствую Вас Гость
Продажа авто б.у.  |  Авторынок   |  Автосалоны   |   Отзывы  |  Тест драйв |  ИнформГалерея |  >>  
Продажа авто Ford »
Россия Беларусь
Ford Aerostar
Ford Bronco
Ford Capri
Ford Cougar
Ford Crown
Ford Econoline
Ford Escape
Ford Escort
Ford Excursion
Ford Expedition
Ford Explorer
Ford Fiesta
Ford Focus
Ford Focus C-Max
Ford Focus
Hatchback II

Ford Freestar
Ford Fusion
Ford GT
Ford Galaxy
Ford Granada
Ford Ka
Ford Kuga
Ford Maverick
Ford Mondeo
Ford Mustang
Ford Orion
Ford Probe
Ford Puma
Ford Ranger
Ford S-MAX
Ford Scorpio
Ford Sierra
Ford Taunus
Ford Taurus
Ford Tempo
Ford Thunderbird
Ford Transit
Ford Windstar
Форд Aerostar
Форд Bronco
Форд Capri
Форд Cougar
Форд Crown
Форд Courier
Форд Econoline
Форд Escape
Форд Escort
Форд Expedition
Форд Explorer
Форд Fiesta
Форд Focus
Форд Focus C-Max
Форд Focus
Hatchback II
Форд Freestar
Форд Fusion
Форд GT
Форд Galaxy
Форд Granada
Форд Ka
Форд Mercury
Форд Mondeo
Ford Mustang
Ford Orion
Ford Probe
Форд Scorpio
Ford Sierra
Форд Taunus
Ford Taurus
Форд Tempo
Форд Thunderbird
Ford Tourneo Connect
Форд Transit
Ford Windstar
Архив записей



Оцените Ford Transit
Всего ответов: 265
Ford tegi


Главная » 2013 » Ноябрь » 29 » Ford Ka 2014 новый концепт от концерна Форд
Ford Ka 2014 новый концепт от концерна Форд
Новое поколение Ford Ka должно поступить в продажу в 2014 году. Новый Ford Ka стал очень похож на Ford Fiesta. Мы видим уже знакомые черты нового модельного ряда Ford, например переднюю решетку в стиле Aston Martin. Судя по фото, форд ка уже кажется, в значительной степени готовой к производству. Полные спецификации нового поколения Ford Ka пока не объявлены, но бразильские СМИ сообщают, что автомобиль возможно получит 1,0-литровый атмосферный двигатель мощностью 80 л.с., а также 1,5-литровый двигатель мощностью 107 л.с., который может работать на этаноле и бензине. Планируется, что обновленное поколение Ford Ka поступит в продажу сначала в Бразилии, а затем в других развивающихся рынках. Ford пока не решил, будет ли поставлять автомобиль в Европу.
Прикрепления: Картинка 1
Просмотров: 13660 | Добавил: Палыч | Теги: форд, 2014, ka, Ford, концерн, Концепт, новый | Рейтинг: 5.0/1
1 prograf  
Tacrolimus (also FK-506 or fujimycin, trade names Prograf, Advagraf, Protopic) is an immunosuppressive pharmaceutical that is mainly in use accustomed to after allogeneic organ move to compress the endeavour of the perseverant's exempt system and so bring the imperil of medium rejection. It is also occupied in a local preparation in the treatment of atopic dermatitis (eczema), harsh refractory uveitis after bone marrow transplants, exacerbations of tiniest metamorphose blight, and the husk train vitiligo.
It is a 23-membered macrolide lactone discovered in 1984 from the fermentation broth of a Japanese filth sample that contained the bacteria Streptomyces tsukubaensis. It reduces interleukin-2 (IL-2) production during T-cells.
Olden days
Tacrolimus was discovered in 1984; it was middle the maiden macrolide immunosuppressants discovered, preceded at near the disclosure of rapamycin (sirolimus) on Rapa Nui (Easter Island) in 1975.<> - It is produced by a class of soil bacterium,Streptomyces tsukubaensis.<> - The high regard tacrolimus is derived from 'Tsukuba macrolide immunosuppressant'.<> -
Tacrolimus was to begin approved via the Comestibles and Cure-all Superintendence (FDA) in 1994 for utilization in liver transplantation; this has been extended to number kidney, resolution, small bowel, pancreas, lung, trachea, overlay, cornea, bone marrow, and limb transplants.
The branded manifestation of the medicate is owned by Astellas Pharma, and is sold below the vocation names Prograf assumption twice daily,Advagraf, a unceasing releasing formulation allowing in the good old days daily dosing, and Protopic (Eczemus in Pakistan by Brookes Pharma), the topical formulation.<> - Advagraf is at one's fingertips in 0.5, 1, 3 and 5 mg capsules, the ointment is concentrations of 0.1% and 0.03%.
A other once-daily formulation of tacrolimus is in Phase 3 clinical trials in the U.S. and Europe. This formulation also has a smoother pharmacokinetic list that reduces the peak-to-trough range in blood levels compared to twice-daily tacrolimus.<> - Materials from the premier Viewpoint 3 contest in steady kidney move patients showed that this once-daily formulation was non-inferior in efficacy and shelter compared to twice-daily tacrolimus.<> - A aid Phase 3 litigation in de novo patients is ongoing.<> -
Mechanism of strength
Tacrolimus is chemically known as a macrolide. In T-cells, activation of the T-cell receptor normally increases intracellular calcium, which acts via calmodulin to actuate calcineurin. Calcineurin then dephosphorylates the transcription go-between NF-AT (atomic part of activated T-cells), which moves to the nucleus of the T-cell and increases the motion of genes coding benefit of IL-2 and common cytokines. Tacrolimus prevents the dephosphorylation of NF-AT.<> - In charge, Tacrolimus reduces peptidyl-prolyl isomerase vocation via binding to the immunophilin FKBP12 (FK506 binding protein) creating a new complex. This FKBP12-FK506 complex interacts with and inhibits calcineurin and so inhibiting both T-lymphocytesignal transduction and IL-2 transcription.<> - Although this liveliness is correspond to to ciclosporin, studies secure shown that the frequency of acute renunciation is reduced nearby tacrolimus exigency execrate above ciclosporin.<>0 - Although short-term immunosuppression anent submissive and extortion survival is institute to be similar between the two drugs, tacrolimus results in a more favorable lipid good, and this may eat leading long-term implications fact the prognostic act upon of renunciation on corruption survival.<>1 -

Ford galereia

Ford v avtonovostiax

Добавлять комментарии могут только зарегистрированные пользователи.
[ Регистрация | Вход ]
© Пользовательское соглашение dafordu.ru 2019